The Correlation Between MYO9B Gene Polymorphism and Inflammatory Bowel Disease in the Guangxi Zhuang Population

References

• Liu TC, Stappenbeck TS. Genetics and pathogenesis of inflammatory bowel disease. Annu Rev Pathol. 2016;11:127–148. doi:10.1146/annurev-pathol-012615-044152
   PubMed Web of Science ®Google Scholar
• Hu S, Vich Vila A, Gacesa R, et al. Whole exome sequencing analyses reveal gene-microbiota interactions in the context of IBD. Gut. 2021;70:285–296.
   PubMed Web of Science ®Google Scholar
• Graham DB, Xavier RJ. Pathway paradigms revealed from the genetics of inflammatory bowel disease. Nature. 2020;578:527–539. doi:10.1038/s41586-020-2025-2
   PubMed Web of Science ®Google Scholar
• Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature. 2007;448(7152):427–434. doi:10.1038/nature06005
   PubMed Web of Science ®Google Scholar
• He W-Q, Wang J, Sheng J-Y, et al. Contributions of myosin light chain kinase to regulation of epithelial paracellular permeability and mucosal homeostasis. Int J Mol Sci. 2020;21(3):993. doi:10.3390/ijms21030993
   PubMed Web of Science ®Google Scholar
• Allam-Ndoul B, Castonguay-Paradis S, Veilleux A. Gut microbiota and intestinal trans-epithelial permeability. Int J Mol Sci. 2020;21(17):6402. doi:10.3390/ijms21176402
   PubMed Web of Science ®Google Scholar
• Schulzke JD, Bojarski C, Zeissig S, et al. Disrupted barrier function through epithelial cell apoptosis. Ann N Y Acad Sci. 2006;1072:288–299. doi:10.1196/annals.1326.027
   PubMed Web of Science ®Google Scholar
• Liping S, Shen L, Clayburgh DR, et al. Targeted epithelial tight junction dysfunction causes immune activation and contributes to development of experimental colitis. Gastroenterology. 2009;136(2):551–563. doi:10.1053/j.gastro.2008.10.081
   PubMed Web of Science ®Google Scholar
• Sánchez de Medina F, Romero-Calvo I, Mascaraque C, Martínez-Augustin O. Intestinal inflammation and mucosal barrier function. Inflamm Bowel Dis. 2014;20(12):2394–2404. doi:10.1097/MIB.0000000000000204
   PubMed Web of Science ®Google Scholar
• Kurashima Y, Kiyono H. Mucosal ecological network of epithelium and immune cells for gut homeostasis and tissue healing. Annu Rev Immunol. 2017;35:119–147. doi:10.1146/annurev-immunol-051116-052424
   PubMed Web of Science ®Google Scholar
• Frenkel S, Bernstein CN, Sargent M, et al. Genome-wide analysis identifies rare copy number variations associated with inflammatory bowel disease. PLoS One. 2019;14:e0217846. doi:10.1371/journal.pone.0217846
   PubMed Web of Science ®Google Scholar
• Martini E, Krug SM, Siegmund B, Neurath MF, Becker C. Mend your fences: the epithelial barrier and its relationship with mucosal immunity in inflammatory bowel disease. Cell Mol Gastroenterol Hepatol. 2017;4(1):33–46. doi:10.1016/j.jcmgh.2017.03.007
   PubMed Web of Science ®Google Scholar
• Shigetomi K, Ikenouchi J. Regulation of the epithelial barrier by post- translational modifications of tight junction membrane proteins. J Biochem. 2018;163:265–272. doi:10.1093/jb/mvx077
   PubMed Web of Science ®Google Scholar
• Foerster E, Mukherjee T, Cabral-Fernandes L, et al. How autophagy controls the intestinal epithelial barrier. Autophagy. 2021:1–18. doi:10.1080/15548627.2021.1909406
   Web of Science ®Google Scholar
• Lu RY, Yang WX, Hu YJ. The role of epithelial tight junctions involved in pathogen infections. Mol Biol Rep. 2014;41:6591–6610. doi:10.1007/s11033-014-3543-5
   PubMed Web of Science ®Google Scholar
• Fries W, Belvedere A, Vetrano S. Sealing the broken barrier in IBD: intestinal permeability, epithelial cells and junctions. Curr Drug Targets. 2013;14(12):1460–1470. doi:10.2174/1389450111314120011
   PubMed Web of Science ®Google Scholar
• McGovern Dermot PB, Kugathasan S, Cho JH. Genetics of inflammatory bowel diseases. Gastroenterology. 2015;149(5):1163. doi:10.1053/j.gastro.2015.08.001
   PubMed Web of Science ®Google Scholar
• Wolters VM, Xu W, Zhao X, et al. Replication of genetic variation in the MYO9B gene in crohn’s disease. Hum Immunol. 2011;72(7):592–597. doi:10.1016/j.humimm.2011.03.025
   PubMed Web of Science ®Google Scholar
• Garg A, Zhao A, Erickson SL, et al. Pregnane X receptor activation attenuates inflammation-associated intestinal epithelial barrier dysfunction by inhibiting cytokine-induced myosin light-chain kinase expression and c-Jun N-terminal kinase 1/2 activation. J Pharmacol Exp Ther. 2016;359(1):91–101. doi:10.1124/jpet.116.234096
   PubMed Web of Science ®Google Scholar
• Hemkemeyer SA, Vollmer V, Schwarz V, et al. Local Myo9b RhoGAP activity regulates cell motility. J Biol Chem. 2021;296:100136. doi:10.1074/jbc.RA120.013623
   PubMed Web of Science ®Google Scholar
• Monsuur AJ, De Bakker PIW, Alizadeh BZ, et al. Myosin IXB variant increases the risk of celiac disease and points toward a primary intestinal barrier defect. Nat Genet. 2005;37(12):1341–1344. doi:10.1038/ng1680
   PubMed Web of Science ®Google Scholar
• Chandhoke SK, Mooseker MS. A role for myosin IXb, a motor-RhoGAP chimera, in epithelial wound healing and tight junction regulation. Mol Biol Cell. 2012;23:2468–2480. doi:10.1091/mbc.e11-09-0803
   PubMed Web of Science ®Google Scholar
• Hegan PS, Chandhoke SK, Barone C, et al. Mice lacking myosin IXb, an inflammatory bowel disease susceptibility gene, have impaired intestinal barrier function and superficial ulceration in the ileum. Cytoskeleton. 2016;73(4):163–179. doi:10.1002/cm.21292
   PubMed Web of Science ®Google Scholar
• Sanchez E, Alizadeh BZ, Valdigem G, et al. MYO9B gene polymorphisms are associated with autoimmune diseases in Spanish population. Hum Immunol. 2007;68:610–615. doi:10.1016/j.humimm.2007.03.006
   PubMed Web of Science ®Google Scholar
• Van Bodegraven AA, Curley CR, Hunt KA, et al. Genetic variation in myosin IXB is associated with ulcerative colitis. Gastroenterology. 2006;131(6):1768–1774. doi:10.1053/j.gastro.2006.09.011
   PubMed Web of Science ®Google Scholar
• Latiano A, Palmieri O, Valvano MR, et al. The association of MYO9B gene in Italian patients with inflammatory bowel diseases. Aliment Pharmacol Ther. 2008;27(3):241–248. doi:10.1111/j.1365-2036.2007.03551.x
   PubMed Web of Science ®Google Scholar
• Wang MJ, Xu XL, Yao GL, et al. MYO9B gene polymorphisms are associated with the risk of inflammatory bowel diseases. Oncotarget. 2016;7(37):58862–58875. doi:10.18632/oncotarget.11186
   PubMedGoogle Scholar
• Hu J, Mei Q, Huang J, et al. Association of MYO9B gene polymorphisms with inflammatory bowel disease in Chinese Han population. World J Gastroenterol. 2014;20(23):7466–7472. doi:10.3748/wjg.v20.i23.7466
   PubMed Web of Science ®Google Scholar
• Torres J, Ellul P, Langhorst J, et al. European crohn’s and colitis organisation topical review on complementary medicine and psychotherapy in inflammatory bowel disease. J Crohns Colitis. 2019;13(6):673–85e. doi:10.1093/ecco-jcc/jjz051
   PubMed Web of Science ®Google Scholar
• Loy L, Roda G, Fiorino G, et al. Detection and management of early stage inflammatory bowel disease: an update for clinicians. Expert Rev Gastroenterol Hepatol. 2019;13(6):547–555. doi:10.1080/17474124.2019.1605291
   PubMed Web of Science ®Google Scholar
• Powell JJ, Cook WB, Hutchinson C, et al. Dietary fortificant iron intake is negatively associated with the quality of life in patients with mildly active inflammatory bowel diseases. Nutr Metab. 2013;10:9. doi:10.1186/1743-7075-10-9
   Google Scholar
• Queiroz NSF, Regueiro M. Safety considerations with biologics and new inflammatory bowel disease therapies. Curr Opin Gastroenterol. 2020;36:257–264. doi:10.1097/MOG.0000000000000607
   PubMed Web of Science ®Google Scholar